Depression screening and patient outcomes in cancer: A systematic review

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Meijer, Anna ^a   Roseman, Michelle ^b,c   Milette, Katherine ^b,c   Coyne, James C ^a,d   Stefanek, Michael E ^e   Ziegelstein, Roy C ^f   Arthurs, Erin ^b   Leavens, Allison ^b   Palmer, Steven C ^d   Stewart, Donna E ^g,h   de Jonge, Peter ^a   Thombs, Brett D ^b,c  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e INDIANA UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CANCER PATIENT; CLINICAL ASSESSMENT TOOL; CLINICAL EFFECTIVENESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXPLORATORY RESEARCH; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR DEPRESSION; PATIENT CARE; PREDICTIVE VALUE; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; NEOPLASM; PROGNOSIS;

DEPRESSIVE DISORDER, MAJOR; HUMANS; NEOPLASMS; PROGNOSIS; SENSITIVITY AND SPECIFICITY;

EID: 81055145725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027181     Document Type: Review

References (68)

1. American Cancer Society (2010) Cancer facts & figures 2010 Atlanta American Cancer Society.
2. Altekruse SF, Kosry CL, Krapcho M, Neyman N, Aminou R, et al. (2011) SEER cancer statistics review, 1975-2007 Bethesda, MD National Cancer Institute.
3. National Comprehensive Cancer Network (2008) Distress Management. NCCN clinical practice guidelines in oncology. http://www.nccn.org/professionals/physician_gls/PDF/distress.pdf.
4. Institute of Medicine (2007) Cancer care for the whole patient: meeting psychosocial health needs Washington, DC National Academy Press.
5. Ng CG, Boks MP, Zainal NZ, De Wit NJ, (2011) The prevalence and pharmacotherapy of depression in cancer patients. J Affect Disord 131: 1-7.
6. Massie MJ, (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32: 57-71.
7. National Institute for Clinical Excellence (2004) Guideline on cancer services: Improving supportive and palliative care for adults with cancer UK National Institute for Clinical Excellence.
8. Patrick DL, Ferketich SL, Frame PS, Harris JJ, Hendricks CB, et al. (2003) National Institutes of Health State-of-the-Science Conference Statement: Symptom Management in Cancer: Pain, Depression, and Fatigue, July 15-17, 2002. J Natl Cancer Inst 95: 1110-7.
9. Thombs BD, Coyne JC, Cuijpers P, de Jonge P, Gilbody S, et al. (2011) Rethinking recommendations for screening for depression in primary care. CMAJ [Epub ahead of print].
10. UK National Screening Committee (2000) Second report of the UK National Screening Committee. Departments of Health for England, Scotland, Northern Ireland and Wales.
11. Raffle A, Gray M, (2007) Screening: Evidence and Practice UK Oxford University Press.
12. Wilson JM, Jungner G, (1968) Principles and practices of screening for disease Geneva World Health Organization.
13. U.S. Preventive Services Task Force (2002) Screening for depression: recommendations and rationale. Ann Intern Med 136: 760-4.
14. Harris RP, Helfand M, Woolf SH, Lohr KN, Mulrow CD, et al. (2001) Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med 3 (Suppl): 21-35.
15. Bakkalbasi N, Bauer K, Glover J, Wang L, (2006) Three options for citation tracking: Google Scholar, Scopus and Web of Science. Biomed Digit Libr 3: 7.
16. ClinicalTrials.gov. Available at: http://www.clinicaltrials.gov. Accessed February 20, 2011.
17. International Standard Randomised Controlled Trial Number Register. Available at: http://www.controlled-trials.com/isrctn. Accessed February 20, 2011.
18. First MB, Spitzer RL, Gibbon M, Williams J, (1996) Structured Clinical Interview for DSM-IV Axis I Disorders- Patient Edition (SCID-I/P, Version 2.0) New York Biometrics Research Department, New York State Psychiatric Institute.
19. Wittchen HU, (1994) Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28: 57-84.
20. Robins LN, Helzer JE, Croughan J, Ratcliff KS, (1981) National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity. Arch Gen Psychiatry 38: 381-9.
21. Mitchell AJ, Zimmerman M, (2010) Is the syndrome of depression a valid concept? In: Mitchell AJ, Coyne JC, editors. Screening for depression in clinical practice: An evidence-based guide New York Oxford University Press pp. 3-28.
22. Thombs BD, de Jonge P, Coyne JC, Whooley MA, Frasure-Smith N, et al. (2008) Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA 300: 2161-71.
23. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J, (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 3: 25.
24. Chapter 8: Assessing risk of bias in included studies (2009) Higgins JPT, Altman DG, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.0.2 The Cochrane Collaboration.
25. Agresti A, Coull BA, (1998) Approximate is better than "exact" for interval estimation of binomial proportions. Am Stat 52: 119-26.
26. Hedges LV, (1982) Estimation of effect size from a series of independent experiments. Psychol Bull 92: 490-9.
27. Rosenthal R, Rosnow RL, Rubin DB, (2000) Contrasts and effect sizes in behavioral research: A correlational approach Cambridge, UK Cambridge University Press.
28. Rosenthal R, DiMatteo MR, (2001) Meta-analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol 52: 59-82.
29. Coyne JC, Palmer SC, Shapiro PJ, Thompson R, DeMichele A, (2004) Distress, psychiatric morbidity, and prescriptions for psychotropic medication in a breast cancer waiting room sample. Gen Hosp Psychiatry 26: 121-8.
30. Alexander S, Palmer C, Stone PC, (2010) Evaluation of screening instruments for depression and anxiety in breast cancer survivors. Breast Cancer Res Treat 122: 573-8.
31. Akechi T, Okuyama T, Sugawara Y, Shima Y, Furukawa TA, et al. (2006) Screening for depression in terminally ill cancer patients in Japan. J Pain Symptom Manage 31: 5-12.
32. Grassi L, Sabato S, Rossi E, Marmai L, Biancosino B, (2009) Affective syndromes and their screening in cancer patients with early and stable disease: Italian ICD-10 data and performance of the Distress Thermometer from the Southern European Psycho-Oncology Study (SEPOS). J Affect Disord 114: 193-9.
33. Hopwood P, Howell A, Maguire P, (1991) Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer 64: 353-6.
34. Houts AC, Lipinski D, Olsen JP, Baldwin S, Hasan M, (2010) Use of the Patient Care Monitor to screen for depression in adult cancer patients interviewed with the structured clinical interview for DSM-IV. Psychooncology 19: 399-407.
35. Krespi Boothby MR, Hill J, Holcombe C, Clark L, Fisher J, et al. (2010) The accuracy of HADS and GHQ-12 in detecting psychiatric morbidity in breast cancer patients. Turk Psikiyatri Derg 21: 49-59.
36. Kugaya A, Akechi T, Okuyama T, Okamura H, Uchitomi Y, (1998) Screening for psychological distress in Japanese cancer patients. Jpn J Clin Oncol 28: 333-8.
37. Lloyd-Williams M, Friedman T, Rudd N, (2001) An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 22: 990-6.
38. Lloyd-Williams M, Friedman T, Rudd N, (2000) Criterion validation of the Edinburgh Postnatal Depression Scale as a screening tool for depression in patients with advanced metastatic cancer. J Pain Symptom Manage 20: 259-65.
39. Lloyd-Williams M, Shiels C, Dowrick C, (2007) The development of the Brief Edinburgh Depression Scale (BEDS) to screen for depression in patients with advanced cancer. J Affect Disord 99: 259-64.
40. Love AW, Kissane DW, Bloch S, Clarke D, (2002) Diagnostic efficiency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer. Aust N Z J Psychiatry 36: 246-50.
41. Love AW, Grabsch B, Clarke DM, Bloch S, Kissane DW, (2004) Screening for depression in women with metastatic breast cancer: a comparison of the Beck Depression Inventory Short Form and the Hospital Anxiety and Depression Scale. Aust N Z J Psychiatry 38: 526-31.
42. Meyer HA, Sinnott C, Seed PT, (2003) Depressive symptoms in advanced cancer. Part 1. Assessing depression: the Mood Evaluation Questionnaire. Palliat Med 17: 596-603.
43. Murphy H, Susana A, Patric S, (2006) Investigation of diagnostic criteria for cancer-related fatigue syndrome in patients with advanced cancer: A feasibility study. Palliative Med 20: 413.
44. Özalp E, Soygur H, Cankurtaran E, Turhan L, Akbiyik D, et al. (2008) Psychiatric morbidity and its screening in Turkish women with breast cancer: a comparison between the HADS and SCID tests. Psychooncology 17: 668-75.
45. Passik SD, Kirsh KL, Donaghy KB, Theobald DE, Lundberg JC, et al. (2001) An attempt to employ the Zung Self-Rating Depression Scale as a "lab test" to trigger follow-up in ambulatory oncology clinics: criterion validity and detection. J Pain Symptom Manage 21: 273-81.
46. Patel D, Sharpe L, Thewes B, Rickard J, Schnieden V, et al. (2010) Feasibility of using risk factors to screen for psychological disorder during routine breast care nurse consultations. Cancer Nurs 33: 19-27.
47. Smith AB, Wright EP, Rush R, Stark DP, Velikova G, et al. (2006) Rasch analysis of the dimensional structure of the Hospital Anxiety and Depression Scale. Psychooncology 15: 817-27.
48. Walker J, Postma K, McHugh GS, Rush R, Coyle B, et al. (2007) Performance of the Hospital Anxiety and Depression Scale as a screening tool for major depressive disorder in cancer patients. J Psychosom Res 63: 83-91.
49. Strong V, Waters R, Hibberd C, Murray G, Wall L, et al. (2008) Management of depression for people with cancer (SMaRT oncology 1): a randomised trial. Lancet 372: 40-8.
50. Egger M, Davey Smith G, O'Rourke K, (2001) Rationale, potentials, and promise of systematic reviews. In: Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed London BMJ Books pp. 3-22.
51. Dawes RM, Faust D, Meehl PE, (1989) Clinical versus actuarial judgment. Science 243: 1668-74.
52. Thombs BD, Arthurs E, El-Baalbaki G, Meijer A, Ziegelstein RC, et al. (2011) Risk of bias from inclusion of patients who already have a diagnosis or are undergoing treatment for depression in diagnostic accuracy studies of screening tools for depression: systematic review. BMJ 343: d4825.
53. Gilbody S, Bower P, Fletcher J, Richards D, Sutton AJ, (2006) Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Arch Intern Med 166: 2314-21.
54. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, et al. (2005) Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 58: 175-89.
55. Ell K, Xie B, Quon B, Quinn DI, Dwight-Johnson M, et al. Randomized controlled trial of collaborative care management of depression among low-income patients with cancer. J Clin Oncol 26: 4488-96.
56. Söllner W, Maislinger S, König A, Devries A, Lukas P, (2004) Providing psychosocial support for breast cancer patients based on screening for distress within a consultation-liaison service. Psychooncology 13: 893-7.
57. Van Scheppingen C, Schroevers MJ, Smink A, Van der Linden YM, Mul VE, et al. (2011) Does screening for distress uncover meetable unmet needs in cancer patients? Psychooncology 20: 655-663.
58. National Collaborating Center for Mental Health (2010) The NICE guideline on the management and treatment of depression in adults (Updated edition) UK National Institute for Health and Clinical Excellence.
59. Palmer SC, Coyne JC, (2003) Screening for depression in medical care: pitfalls, alternatives, and revised priorities. J Psychosom Res 54: 279-87.
60. Gilbody SD, Sheldon TD, House AD, (2008) Screening and case-finding instruments for depression: a meta-analysis. CMAJ 178: 997-1003.
61. U.S. Preventive Services Task Force (2009) Screening for depression in adults: U.S. preventive services task force recommendation statement. Ann Intern Med 151: 784-92.
62. Bower P, Gilbody S, Richards D, Fletcher J, Sutton A, (2006) Collaborative care for depression in primary care. Making sense of a complex intervention: systematic review and meta-regression. Br J Psychiatry 189: 484-93.
63. Kelly CM, Juurlink DN, Gomes T, Duong-Hua M, Pritchard KI, et al. (2010) Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 340: c693.
64. Yap KY, Ho YX, Chui WK, Chan A, (2010) Harnessing the internet cloud for managing drug interactions with chemotherapy regimens in patients with cancer suffering from depression. Acta Oncol 49: 1235-45.
65. Cronin-Fenton D, Lash TL, Sorensen HT, (2010) Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality. Future Oncol 6: 877-80.
66. Lash TL, Cronin-Fenton D, Ahern TP, Rosenberg CL, Lunetta KL, et al. (2010) Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol 49: 305-12.
67. Alfaro CL, Lam YW, Simpson J, Ereshefsky L, (2000) CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations. J Clin Pharmacol 40: 58-66.
68. Saylor MS, Smetana RF, (2010) Potential for drug-drug interactions in treating cancer-related nausea and distress. J Oncol Pharm Pract [Epub ahead of print].